What Vitestro Builds

Vitestro builds automated phlebotomy devices for diagnostic laboratories, outpatient blood draw centers, and hospital networks. Its core technology automates routine venipuncture so medical centers can complete high-volume diagnostic blood collection with fewer bedside phlebotomists. The primary hardware product houses patient positioning armrests, multispectral vein detection cameras, an ultrasound imaging probe, and automated needle insertion tools inside an enclosed kiosk. Patients insert their forearm into a padded cradle. The system detects suitable veins automatically, which prevents repeated unsuccessful needle sticks on difficult injection sites. Mechanical grippers uncap collection tubes, fill them with exact specimen volumes, invert them to mix anticoagulants properly, and label them for laboratory processing. This automated sample handling stops mislabeling errors before tubes reach diagnostic analyzers. Vitestro markets its hardware through commercial equipment leases and per-procedure service contracts. Customers pay recurring software license fees and purchase proprietary single-use consumable packs for each patient draw. These disposable packs contain sterile needles and tubing cartridges, guaranteeing clean patient contact points without requiring manual sterilization between appointments.

Vitestro Robots and Models

These are the Vitestro models a buyer is most likely to be evaluating, and what each one actually does.

  • Aletta — Aletta is an autonomous medical phlebotomy cart designed for high-throughput outpatient venipuncture. Near-infrared cameras locate superficial arm veins. An integrated ultrasound probe scans tissue depth, which lets the robotic needle mount guide cannula entry into veins with sub-millimeter precision. Automated tube mixers invert blood samples immediately after collection to prevent early clotting. Vitestro manufactures only this single model. The system currently draws blood exclusively from adult arm veins, requiring clinical facilities to maintain human phlebotomists for pediatric patients and difficult specialized draws.

Vitestro Pricing and Availability

Vitestro does not publish fixed capital acquisition prices for its hardware. Total deployment costs depend on facility draw volumes, service-level agreements, and consumable tube pack commitments. Most enterprise diagnostic networks acquire the equipment through long-term operating leases paired with a per-procedure software fee. Under this model, clinics pay an upfront installation and site qualification fee, followed by fixed monthly platform charges. Each collection procedure requires a proprietary single-use sterile kit containing the needle, adapter, and protective sheath. These consumables represent a direct recurring operating expense that scales with patient traffic. Vitestro initially focused commercial deployments in European medical centers, particularly within the Netherlands and select pilot facilities across the European Union (EU). The company has secured regulatory clearance from the Food and Drug Administration (FDA) for use in non-hospital outpatient settings across the United States. Lead times range from three to six months depending on electrical utility prep, physical architectural modifications, and integration work with the site's Laboratory Information System (LIS). Facilities must budget for site networking, operator safety training, and routine preventative maintenance visits.

Who Vitestro Robots Are For

Aletta serves high-throughput outpatient blood collection centers, independent commercial diagnostic laboratories, and ambulatory clinics that process at least one hundred routine adult blood draws daily. These facilities face ongoing staffing shortages. Automating standard draws allows them to process more routine patients each hour while reserving experienced phlebotomists for difficult cases. Sites with predictable patient flows achieve the fastest financial payback by running the hardware across continuous operating shifts. The system does not fit emergency departments or acute inpatient wards where patients cannot sit upright or remain still in a cradle. Pediatric hospitals should look elsewhere because the vein detection system and mechanical arm cradle accommodate only adult arm geometry. Small primary care practices that conduct fewer than twenty draws per day will find the capital expense and floor footprint impractical. Sites that rely on manual vein palpation for fragile, rolling, or sclerotic veins must keep trained nursing staff on hand. Vitestro automates standard, repeatable blood draws rather than complex vascular access scenarios.

  • Laboratory Information System (LIS) integration: Operators must verify that Vitestro software interfaces directly with existing clinical health records. A bidirectional interface transmits patient orders directly to the machine and returns tube barcode identifiers, which eliminates manual barcode scanning and prevents specimen misidentification.
  • Clinical staffing balance: Clinics must retain certified phlebotomists on site during all operating hours. Human clinicians must supervise patient check-in, assist individuals with mobility restrictions, and handle failed automatic venipunctures when the system cannot locate an adequate vein.
  • Consumable supply chain reliance: The machine requires proprietary sterile needle assemblies and tube-handling cartridges for every draw. Procurement managers must evaluate consumable unit pricing and delivery lead times to prevent supply interruptions that would halt clinic operations.
  • Physical footprint and workflow layout: The workstation requires dedicated floor space, clean electrical feeds, and room for patient seating. Clinics must design access pathways that allow staff to restock tubes and empty biohazard waste containers without blocking incoming patient queues.
  • Patient consent and acceptance rates: Medical directors should measure patient willingness to undergo robotic venipuncture before deployment. Facilities typically run manual draw stations alongside autonomous kiosks so hesitant patients or those with acute needle phobias can opt for traditional human care.
  • Sterilization and infection control protocol: Infection control teams must review surface wipe-down intervals and glove-changing workflows between draws. Quick-drying disinfectant procedures keep cycle times brief while maintaining medical-grade hygiene standards across public touchpoints and forearm cradles.

Vitestro Alternatives

Robots and vendors a buyer typically cross-shops against Vitestro.

  • Diligent Robotics — [Diligent Robotics](https://diligentrobots.com) manufactures Moxi, a mobile hospital service robot. Unlike Vitestro, Diligent Robotics builds transport machines rather than phlebotomy hardware. Moxi navigates hospital corridors to deliver drawn blood samples, pharmaceuticals, and lab supplies between wards. It relieves nursing staff of delivery errands while leaving actual venipuncture to human clinical teams.
  • Intuitive Surgical — [Intuitive Surgical](https://www.intuitivesurgical.com) manufactures the da Vinci surgical system for minimally invasive operations. While Vitestro automates needle insertion without direct doctor manipulation, Intuitive Surgical designs surgeon-controlled teleoperated arms for complex hospital surgeries. Intuitive Surgical targets operating rooms with high capital equipment costs rather than high-throughput diagnostic outpatient clinics.
  • Stryker Mako — [Stryker Mako](https://www.stryker.com) provides robotic-arm assisted surgical platforms for orthopedic joint reconstruction. Stryker Mako guides bone cutting under direct surgeon control, whereas Vitestro operates autonomously during venipuncture. Orthopedic surgical robots require sterile hospital operating suites, contrasting sharply with the outpatient clinic environments suited to Vitestro phlebotomy kiosks.
  • Medtronic — [Medtronic](https://www.medtronic.com) produces robotic-assisted surgical equipment such as the Hugo platform along with vascular catheters. Medtronic focuses on acute surgical intervention and implantable medical technology. It does not sell autonomous phlebotomy kiosks, leaving routine diagnostic outpatient blood collection to specialized automation providers like Vitestro.
  • CMR Surgical — [CMR Surgical](https://cmrsurgical.com) builds the Versius system for teleoperated laparoscopic procedures in acute hospital environments. Its modular robotic arms mimic human wrist articulation under direct surgeon control. In contrast, Vitestro creates purpose-built autonomous hardware dedicated strictly to diagnostic blood draws without requiring physician guidance.

Recent news

A dated log of developments, each tied to its primary source.

  • 2026-09 — Vitestro launched Aletta, reported as the first autonomous blood-draw machine approved by the U.S. Food and Drug Administration for use in non-hospital settings, which uses near-infrared imaging, ultrasound, and Doppler to locate a vein and automatically draw blood. IEEE Spectrum Robotics
  • Expansion to pediatric and specialized vascular access: Vitestro has engineered Aletta for adult arm dimensions. Watch for firmware updates and new sensor brackets that accommodate smaller pediatric forearms or alternative venipuncture anatomical sites.
  • Third-party tube and cartridge compatibility: The system relies on custom sterile single-use kits. Watch whether Vitestro opens support for standard off-the-shelf vacuum collection tubes from multiple major medical suppliers to lower consumable costs.
  • Throughput metrics under real-world clinic operations: Field data regarding average total draw time, including patient seating and bandaging, will clarify whether autonomous units match or exceed experienced human phlebotomists during peak laboratory morning rushes.

Bottom Line

Vitestro addresses diagnostic laboratory labor shortages by automating routine adult blood collection. The Aletta platform shifts routine needle insertion and sample handling away from clinical staff, allowing phlebotomists to supervise multiple automated stations or focus on difficult patient cases. High-volume outpatient centers stand to benefit most from the consistency and integrated sample tracking. Facilities considering the system must evaluate their daily draw volumes, consumable expenses, and physical clinic space before committing to commercial lease contracts.

Read our comparative evaluations of clinical automation systems and hospital service robotics to plan your facility deployment.

FAQs

How does the Vitestro Aletta robot locate a patient's vein?

Aletta locates veins using a combination of near-infrared light and ultrasound imaging. The near-infrared illumination maps superficial vascular structures near the skin surface. The ultrasound transducer then glides across the arm to determine vessel depth, diameter, and orientation. This automated dual-sensor scanning guides the needle path with sub-millimeter precision, avoiding blind needle probing and reducing tissue trauma for patients during routine diagnostic blood tests.

Is human supervision required when Vitestro Aletta draws blood?

Yes, trained clinical personnel must remain on site to oversee operations. While the machine carries out vein mapping, needle insertion, tube filling, and bandage placement autonomously, human phlebotomists assist patients into the chair, manage system alerts, and handle difficult vascular access cases. Having staff present ensures patient safety, satisfies facility liability requirements, and provides immediate manual care if a patient feels faint or experiences anxiety.

What regulatory approvals has Vitestro secured for Aletta?

Aletta holds regulatory authorization from the Food and Drug Administration (FDA) for use in non-hospital outpatient facilities across the United States. Vitestro also holds European CE mark certification under the In Vitro Diagnostic Medical Devices Regulation (IVDR) and Medical Device Regulation (MDR). These clearances allow clinical laboratories, outpatient diagnostic facilities, and blood donation networks to operate the equipment commercially under defined medical supervision protocols.

Can Vitestro Aletta perform blood draws on pediatric patients?

No, Aletta is authorized and configured exclusively for adult patients. The physical arm cradle, vein recognition computer vision models, and mechanical needle carriage require standard adult forearm dimensions. Pediatric patients have smaller, more fragile veins and frequently move during medical procedures, which current robotic stabilization clamps cannot safely manage. Clinics caring for children must continue to use experienced human pediatric phlebotomists.

How does Aletta handle sample tubes and labeling?

Aletta manages collection tubes automatically inside an enclosed internal carousel. The robotic system selects the required vacuum tube, unseals it, draws the precise blood volume, and inverts the tube repeatedly to mix anticoagulants properly. It links the specimen directly to the patient record through Laboratory Information System (LIS) integration, applying a verified barcode label before delivery, which eliminates sample mix-ups and pre-analytical labeling errors.

What happens if Vitestro Aletta cannot find a suitable vein?

If Aletta fails to find a suitable vein, it aborts the procedure safely without puncturing the skin. The multispectral vision and ultrasound sensors evaluate whether vein diameter and blood flow meet strict automated insertion criteria. When vessels are too deep, tortuous, or thin, the machine notifies the supervising clinician on the primary display screen. A certified human phlebotomist then completes the draw manually at an adjacent station.

Primary Sources